USChina Trade Divergence Persists Following APEC Meetings Understanding TaxEfficient Account Placement for Retirement and Brokerage Investments SpaceX Scrubs Starship Test Flight Reschedules for Friday as V3 Debut Approaches Dog Club Treasurer Admits to 20000 Fraud Lessons in Nonprofit Financial Controls King Yuan Electronics Expands Global Footprint with New Singapore Facility Creating Over 300 Jobs Disneys The Mandalorian and Grogu Opens to LowestEver Star Wars Box Office at 82 Million Instil Bio Inc TIL Q1 2026 Earnings WiderThanExpected Loss as Biotech Continues PreCommercial Phase Murphy USA MUSA Q1 2026 Earnings Strong EPS Beat of 415 Drives Investor Focus on Operational Efficiency GAINN Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines Bank of Hawaii Q1 2026 Earnings EPS Misses Estimates Stock Declines Marginally Via Transportation Inc VIA Q1 2026 Earnings Narrower Loss Beats Estimates Amid Strategic Shift Digimarc Q1 2026 Earnings EPS Surpasses Estimates Despite Stock Decline TIM SA TIMB Slips 146 as Shares Test Support Near 2119 Omnicom Group Edges Lower as Sector Headwinds Persist OMC Holds Above Key Support TrioTech International TRT Surges Over 20 Key Levels and Technical Setup Howard Hughes Holdings HHH Holds Steady Near 6450 as Support and Resistance Levels Tighten Stanley Black Decker SWK Posts Modest Gain Consolidating Near Support GLP1 Weight Loss Drugs Driving Up Prescription Costs CoPays Expected to Rise PRVA Q1 2026 Earnings EPS Miss Puts Focus on Cost Management and Growth Trajectory Apogee Therapeutics APGE Edges Lower as Biotech Sentiment Wavers Barclays Reports 18 Profit Increase Upgrades FullYear Income Guidance OpenAI IPO Filing Could Signal New Era for AI Companies in Public Markets US Prioritizes American AI Integration in Asia Following TrumpXi Meeting Indian Equities Face Continued FPI Selling Pressure as Outflows Top 220 Lakh Crore in 2026 SP 500 Recovers as Tech Surge Offsets Energy Rout Dow Slips Microsoft and Anthropic Explore Custom AI Chip Partnership Following 5 Billion Investment Viatris Inc Analysts Weigh PostMerger Strategy and Generic Drug Portfolio Outlook